Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant Women

NCT05264662 is registered in ClinicalTrials.gov with Farzanah Laher as lead sponsor.

NCT NCT05264662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05264662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant Women
Lead sponsor
Farzanah Laher
Phase
Phase 4
Overall status
Completed
Start date
March 8, 2022
Completion date
March 12, 2025
Enrollment
511 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dtap vaccine